Similar Articles
Immune checkpoint inhibitor-related myositis with ocular manifestations and fatal outcome
Nuri Tuğra Uslucan, Merve Yavuz, Esra Aşıkdoğan, Emre Kumral
DOI: 10.55697/tnd.2025.497
Issue: 2025, Volume 31 - Issue 4
1996
1247
Clinical prediction model for early neurological deterioration in patients with mild nondisabling ischemic stroke within 4.5 hours of onset
Lin Lu, Hongying Ma
DOI: 10.55697/tnd.2026.575
Issue: 2026, Volume 32 - Issue 1
1969
1064
Global infodemiological trends in Parkinson’s disease-associated sleep disorders: Long-term digital impact of the COVID-19 pandemic
Esra Demir Ünal, Selim Selçuk Çomoğlu
DOI: 10.55697/tnd.2026.611
Issue: 2026, Volume 32 - Issue 1
1728
1139
Evaluation of the risk factors and clinical features of newly developing cerebral microbleeds following internal carotid artery stenting
Yasemin Dinc, Rıfat Özpar, Emel Oguz Akarsu, Furkan Sarıdas, Gizem Güllü, Mustafa Bakar, Bahattin Hakyemez
DOI: 10.55697/tnd.2026.585
Issue: 2026, Volume 32 - Issue 3
251
135


